• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天冬氨酸814在c-kit受体酪氨酸激酶的功能及表达中的作用

Role of aspartic acid 814 in the function and expression of c-kit receptor tyrosine kinase.

作者信息

Moriyama Y, Tsujimura T, Hashimoto K, Morimoto M, Kitayama H, Kitamura Y, Kanakura Y

机构信息

Department of Internal Medicine II, Osaka University Medical School, Yamadaoka 2-2, Suita 565, Japan.

出版信息

J Biol Chem. 1996 Feb 16;271(7):3347-50. doi: 10.1074/jbc.271.7.3347.

DOI:10.1074/jbc.271.7.3347
PMID:8631931
Abstract

The c-kit receptor tyrosine kinase (KIT) is constitutively activated in three different types of neoplastic mast cell lines by naturally occurring mutations that result in substitutions of Val or Tyr for Asp814 in the phosphotransferase domain. In an effort to characterize the role of the Asp814 residue, we have investigated the properties of mutant KITs in which the Asp814 residue was deleted or mutated to a series of other amino acids. With the exception of rare instances, mutant KITs with substitutions of Asp814 were found to be constitutively phosphorylated on tyrosine and activated in the absence of the ligand, stem cell factor (SCF), whereas a deletion mutant lacking Asp814 (KITDel-Asp-814) did not exhibit tyrosine phosphorylation and activation even after treatment with SCF. In addition to constitutive activation, furthermore, both highly activated substitution mutants (KITVal-814 and KITTyr-814) and modestly activated substitution mutants (KITGly-814 and KITHis-814) were continuously degraded in the absence of SCF, whereas wild-type KIT (KITWild) required SCF stimulation to undergo degradation. These results suggested that the Asp814 residue may play a crucial role in regulating enzymatic activity and expression of KIT and that various types of mutations at the Asp814 residue may generate oncogenic protein with constitutive activation and degradation.

摘要

c-kit受体酪氨酸激酶(KIT)在三种不同类型的肿瘤性肥大细胞系中通过自然发生的突变而组成性激活,这些突变导致磷酸转移酶结构域中的天冬氨酸814被缬氨酸或酪氨酸取代。为了表征天冬氨酸814残基的作用,我们研究了突变型KIT的特性,其中天冬氨酸814残基被缺失或突变为一系列其他氨基酸。除了罕见的情况外,发现用天冬氨酸814取代的突变型KIT在酪氨酸上组成性磷酸化,并在没有配体干细胞因子(SCF)的情况下被激活,而缺乏天冬氨酸814的缺失突变体(KITDel-Asp-814)即使在用SCF处理后也未表现出酪氨酸磷酸化和激活。此外,除了组成性激活外,高度激活的取代突变体(KITVal-814和KIT Tyr-814)和适度激活的取代突变体(KITGly-814和KITHis-814)在没有SCF的情况下都会持续降解,而野生型KIT(KITWild)需要SCF刺激才能发生降解。这些结果表明,天冬氨酸814残基可能在调节KIT的酶活性和表达中起关键作用,并且天冬氨酸814残基处的各种类型的突变可能产生具有组成性激活和降解的致癌蛋白。

相似文献

1
Role of aspartic acid 814 in the function and expression of c-kit receptor tyrosine kinase.天冬氨酸814在c-kit受体酪氨酸激酶的功能及表达中的作用
J Biol Chem. 1996 Feb 16;271(7):3347-50. doi: 10.1074/jbc.271.7.3347.
2
Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.在人肥大细胞白血病细胞系中鉴定原癌基因c-kit编码序列中的突变,该突变导致c-kit产物的配体非依赖性激活。
J Clin Invest. 1993 Oct;92(4):1736-44. doi: 10.1172/JCI116761.
3
Activating mutation in the catalytic domain of c-kit elicits hematopoietic transformation by receptor self-association not at the ligand-induced dimerization site.c-kit催化结构域中的激活突变通过受体自身缔合引发造血转化,而非在配体诱导的二聚化位点。
Blood. 1999 Feb 15;93(4):1319-29.
4
Substitution of an aspartic acid results in constitutive activation of c-kit receptor tyrosine kinase in a rat tumor mast cell line RBL-2H3.天冬氨酸的替换导致大鼠肿瘤肥大细胞系RBL - 2H3中c - kit受体酪氨酸激酶的组成型激活。
Int Arch Allergy Immunol. 1995 Apr;106(4):377-85. doi: 10.1159/000236870.
5
Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines.c-kit受体酪氨酸激酶的组成性激活突变赋予因子依赖性造血细胞系不依赖因子的生长和致瘤性。
Blood. 1995 Feb 1;85(3):790-8.
6
Constitutive activation of c-kit in FMA3 murine mastocytoma cells caused by deletion of seven amino acids at the juxtamembrane domain.近膜结构域七个氨基酸的缺失导致FMA3小鼠肥大细胞瘤细胞中c-kit的组成性激活。
Blood. 1996 Jan 1;87(1):273-83.
7
Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation.由点突变产生的小鼠肥大细胞瘤细胞系P-815中c-kit受体酪氨酸激酶的非配体依赖性激活。
Blood. 1994 May 1;83(9):2619-26.
8
Constitutive activation of c-kit by the juxtamembrane but not the catalytic domain mutations is inhibited selectively by tyrosine kinase inhibitors STI571 and AG1296.酪氨酸激酶抑制剂STI571和AG1296可选择性抑制由近膜结构域而非催化结构域突变导致的c-kit组成型激活。
Int J Hematol. 2002 Dec;76(5):427-35. doi: 10.1007/BF02982808.
9
Neoplastic transformation of normal hematopoietic cells by constitutively activating mutations of c-kit receptor tyrosine kinase.c-kit受体酪氨酸激酶的组成性激活突变导致正常造血细胞的肿瘤转化。
Blood. 1996 Aug 1;88(3):995-1004.
10
A point mutation in the catalytic domain of c-kit induces growth factor independence, tumorigenicity, and differentiation of mast cells.c-kit催化结构域中的一个点突变可诱导肥大细胞生长因子非依赖性、致瘤性和分化。
Blood. 1996 Apr 15;87(8):3117-23.

引用本文的文献

1
A GDSL-motif esterase/acyltransferase/lipase is responsible for leaf water retention in barley.一种GDSL基序酯酶/酰基转移酶/脂肪酶负责大麦叶片的保水作用。
Plant Direct. 2017 Nov 3;1(5):e00025. doi: 10.1002/pld3.25. eCollection 2017 Nov.
2
Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells.受体酪氨酸激酶(c-Kit)抑制剂:癌细胞中的一个潜在治疗靶点。
Drug Des Devel Ther. 2016 Aug 1;10:2443-59. doi: 10.2147/DDDT.S89114. eCollection 2016.
3
Distinct classes of c-Kit-activating mutations differ in their ability to promote RUNX1-ETO-associated acute myeloid leukemia.
不同类别的 c-Kit 激活突变在促进 RUNX1-ETO 相关急性髓系白血病的能力上存在差异。
Blood. 2012 Feb 9;119(6):1522-31. doi: 10.1182/blood-2011-02-338228. Epub 2011 Sep 21.
4
Roles for deregulated receptor tyrosine kinases and their downstream signaling molecules in hematologic malignancies.失调的受体酪氨酸激酶及其下游信号分子在血液系统恶性肿瘤中的作用。
Cancer Sci. 2008 Mar;99(3):479-85. doi: 10.1111/j.1349-7006.2007.00717.x. Epub 2008 Jan 2.
5
KIT regulates tyrosine phosphorylation and nuclear localization of beta-catenin in mast cell leukemia.KIT在肥大细胞白血病中调节β-连环蛋白的酪氨酸磷酸化和核定位。
Leuk Res. 2008 May;32(5):761-70. doi: 10.1016/j.leukres.2007.08.023. Epub 2007 Oct 18.
6
Neoplasia driven by mutant c-KIT is mediated by intracellular, not plasma membrane, receptor signaling.由突变型c-KIT驱动的肿瘤形成是由细胞内而非质膜受体信号传导介导的。
Mol Cell Biol. 2007 Jan;27(1):267-82. doi: 10.1128/MCB.01153-06. Epub 2006 Oct 23.
7
Alterations of the c-kit gene in testicular germ cell tumors.睾丸生殖细胞肿瘤中c-kit基因的改变。
Cancer Sci. 2003 Jun;94(6):486-91. doi: 10.1111/j.1349-7006.2003.tb01470.x.
8
Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis.在人类肥大细胞增多症的不同临床形式中,c-KIT催化结构域存在激活型和显性失活型突变。
Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1609-14. doi: 10.1073/pnas.96.4.1609.
9
Uncoupling signal transducers from oncogenic MET mutants abrogates cell transformation and inhibits invasive growth.使致癌性MET突变体的信号转导器解偶联可消除细胞转化并抑制侵袭性生长。
Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14379-83. doi: 10.1073/pnas.95.24.14379.